Press Releases

Advanced Search
  • Nov 16, 2021
    Donations to BrightEdge fund total $2.5 million; Donors include Wood Next Fund and G2 CEO Godard Abel, serial tech entrepreneur.

    The American Cancer Society’s impact investment fund, BrightEdge LLC, today named its first Founder’s Circle members, securing contributions totaling $2.5 million. Launched with an initial $25 million investment from the American Cancer Society (ACS), the mission-driven fund invests in for-profit, early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies. The impact investment donations are BrightEdge’s first since its formation.

  • Nov 11, 2021
    New analysis from the American Cancer Society shows large declines in cancer mortality since 1971 passage of National Cancer Act

    It’s been 50 years since President Nixon signed the National Cancer Act, launching the War on Cancer. How did we do? Substantial progress has been made in the war against cancer, according to...

  • Nov 1, 2021
    American Cancer Society and Canadian Cancer Society Return as Partners

    The National Hockey League (NHL) and National Hockey League Players' Association (NHLPA) announced that their annual Hockey Fights Cancer campaign begins today. Since 1998, the joint initiative...

  • Oct 26, 2021

    Contact: NCI Press Office 240-760-6600 Credit: National Cancer Institute Part 2 of the latest Annual Report to the Nation on the Status of Cancer finds that cancer patients in the United States...

  • Oct 25, 2021
    Grantees will get funding and data to research treatment and disparities among patients with advanced pancreatic and breast cancer

    The American Cancer Society (ACS) and Flatiron Health announced today that the 2021 Real-World Data Impact Awards will support research into health disparities among patients with advanced...

Show 5102550100 per page